CD226 and lung cancer: Treatment of NK92 cells with EVs isolated from the serum of lung cancer patients, decreased their expression of CD226 (Figure 6c), and this effect was significantly, yet weakly, correlated with the level of miR-150-5p in the serum EVs (R = −0.26, p = 0.003) (Figure 6d).